Autres langues Glenmark Life Sciences Limited

Actions

GLS

INE03Q201024

Cours en clôture NSE India S.E. Autres places de cotation 00:00:00 11/07/2024			Varia. 5j.	Varia. 1 janv.
842,2 ^INR	-3,85 %		-7,63 %	+28,17 %

11/07	Glenmark Pharmaceuticals va vendre 7,84% de sa participation dans Glenmark Life Sciences	MT
10/07	Glenmark Pharma vend 7,84% de sa participation dans Glenmark Life Sciences Limited par le biais d'une offre de vente	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Glenmark Pharmaceuticals to Sell 7.84% Stake in Glenmark Life Sciences	11/07
Glenmark Pharma to Sell 7.84% Stake in Glenmark Life via Offer for Sale	10/07
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	15/05
Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	25/04
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	25/04
Glenmark Life Sciences Limited Announces Resignation of Gita Nayyar as Non-Executive, Independent Director	22/04
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12/03
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024	06/03
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.	29/02
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15/02
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14/02
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23/01
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API	19/01
Glenmark Life Sciences Announces Another CDMO Deal	19/01
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10/11
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11
India's Glenmark Life Sciences posts Q2 profit rise on API boost	20/10/23
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Glenmark Life Sciences Limited

Actions

GLS

INE03Q201024

Autres langues

Filtres